Search bioRxiv⌕ Search

Biology subjects

Dhaeseleer, M.

Publications and source records attributed to Dhaeseleer, M..

2 recordsLinked to original sources

Task-induced 1/f slope modulation as a paradigm-independent marker of cognitive control in multiple sclerosis

Multiple sclerosis (MS) is a chronic neuro-degenerative and inflammatory disease causing motor, sensory, and cognitive deficits, including impairments in working memory and attention. These cognitive deficits may arise from an imbalance between excitatory and inhibitory neural activity due to synaptic loss. Recent studies suggest that the aperiodic 1/f slope, a neural marker reflecting excitation/inhibition (E/I) balance, could serve as a biomarker for cognitive control. This study examines 1/f slope modulation during cognitive tasks in people with MS and healthy controls to investigate its potential as a paradigm-independent marker of cognitive control. We analyzed the Magnetoencephalography (MEG) data collected from 126 participants: 44 healthy controls (HCs), 61 people with MS not treated with benzodiazepines (pwMS(BZDn)), and 21 pwMS treated with benzodiazepines (pwMS(BZDp)). Participants performed an auditory oddball task and a visual-verbal n-back working memory task. After preprocessing MEG data, we used the FOOOF algorithm to extract the aperiodic 1/f slope from power spectral densities across 42 cortical parcels. Through this analysis, we observed significant increases in the 1/f slope following stimulus onset for all stimulus types, with more pronounced modulation for non-standard stimuli (targets and distractors), especially within the temporal cortex. Group comparisons revealed less slope modulation in pwMS(BZDp) compared to HCs during distractor stimuli, indicating impaired inhibitory control linked to benzodiazepine treatment. Positive correlations of 1/f slope modulation across auditory oddball and n-back tasks were observed in HCs and pwMS(BZDn), highlighting a consistent, paradigm-independent mechanism. Taken together, these findings demonstrate that the aperiodic 1/f slope is a sensitive, paradigm-independent marker of cognitive control and E/I balance. Reduced modulation in response to distractors among pwMS(BZDp) highlights benzodiazepine-related disruptions in inhibitory neural processes underlying cognitive deficits. These findings underscore the value of aperiodic spectral measures to deepen understanding and potentially guide therapeutic interventions targeting cognitive impairments in MS. HighlightsO_LIThe 1/f slope was significantly modulated during an auditory oddball task across all stimulus types in healthy controls and people with multiple sclerosis (pwMS). C_LIO_LIThis modulation was more pronounced for non-standard stimuli (distractor and target) than for standard stimuli. C_LIO_LIHealthy controls showed a larger 1/f slope modulation (suggesting more inhibition) following distractor trials compared to target trials while, this pattern was reversed in pwMS. C_LIO_LIThis modulation significantly correlated with visuospatial memory, as measured by the BVMT-R, in pwMS not treated with benzodiazepines. C_LIO_LIWe further correlated the 1/f slope modulation during the auditory oddball task with the 1/f slope modulation previously described during a working memory task and observed strong correlations (r=0.4-0.6, p<0.001) across paradigms. C_LI

neuroscience↗

The spectral slope as a marker of excitation/inhibition ratio and cognitive functioning in multiple sclerosis

BackgroundMultiple sclerosis (MS) is a neurodegenerative disease characterized by neuronal and synaptic loss, resulting in an imbalance of excitatory and inhibitory synaptic transmission and potentially cognitive impairment. Current methods for measuring the excitation/inhibition (E/I) ratio are mostly invasive, but recent research combining neurocomputational modeling with measurements of local field potentials has indicated that the slope with which the power spectrum of neuronal activity captured by electro- and/or magnetoencephalography rolls off, is a non-invasive biomarker of the E/I ratio. A steeper roll- off is associated with a stronger inhibition. This novel method can be applied to assess the E/I ratio in people with multiple sclerosis (pwMS), detect the effect of medication such as benzodiazepines, and explore its utility as a biomarker for cognition. MethodsWe recruited 44 healthy control subjects and 95 people with multiple sclerosis (pwMS) who underwent resting-state magnetoencephalographic recordings. The 1/f spectral slope of the neural power spectra was calculated for each subject and for each brain region. ResultsAs expected, the spectral slope was significantly steeper in pwMS treated with benzodiazepines (BZDs) compared to pwMS not receiving BZDs (p = 0.01). In the sub-cohort of pwMS not treated with BZDs, we observed a steeper slope in cognitively impaired pwMS compared to cognitively preserved pwMS (p = 0.01) and healthy subjects (p = 0.02). Furthermore, we observed a significant correlation between 1/f spectral slope and verbal and spatial working memory functioning in the brain regions located in the prefrontal and parietal cortex. ConclusionsIn this study, we highlighted the value of the spectral slope in MS by quantifying the effect of benzodiazepines and by putting it forward as a potential biomarker of cognitive deficits in pwMS.

neuroscience↗